J.P. Marvel Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,240
Closed -$688K 88
2015
Q4
$688K Buy
+4,240
New +$666K 0.24% 61
2015
Q2
$651K Hold
4,240
0.22% 62
2015
Q1
$678K Hold
4,240
0.23% 62
2014
Q4
$675K Hold
4,240
0.23% 65
2014
Q3
$596K Hold
4,240
0.22% 68
2014
Q2
$502K Hold
4,240
0.17% 72
2014
Q1
$523K Hold
4,240
0.18% 68
2013
Q4
$484K Hold
4,240
0.17% 68
2013
Q3
$475K Hold
4,240
0.18% 70
2013
Q2
$418K Buy
+4,240
New +$440K 0.17% 67

Other funds holding AMGN

J.P. Marvel Investment Advisors's AMGN Position: Q1 2016 in Review

J.P. Marvel Investment Advisors sold out of Amgen (AMGN) in Q1 2016, closing a stake of 4,240 shares — an estimated $688K sold.

J.P. Marvel Investment Advisors first reported a position in AMGN in Q2 2013 and held it in 10 quarters. The position peaked at $688K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • J.P. Marvel Investment Advisors reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • J.P. Marvel Investment Advisors sold 4,240 Amgen shares in Q1 2016, an estimated $688K.
  • J.P. Marvel Investment Advisors first reported a position in Amgen in Q2 2013 and held it in 10 quarters.
  • J.P. Marvel Investment Advisors's Amgen position peaked at $688K in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2016, filed 26 May 2016.